YOCAIR 4MG Chewable Tablets: Your Solution for Asthma and Allergy Management

As referenced on Nahdi Online, , and , YOCAIR 4MG Chewable Tablets provide effective management for asthma and allergy symptoms, especially designed for children. Each tablet contains Montelukast, a potent leukotriene receptor antagonist that works to block substances called leukotrienes in the body. These leukotrienes contribute to the inflammation and narrowing of airways in the lungs, triggering asthma symptoms and seasonal allergies.

Product Details

• Active Ingredient: Montelukast Sodium 4mg
• Dosage Form: Chewable Tablets
• Package Size: 30 Tablets
• Primary Use: Prevention and long-term treatment of asthma in patients 2 to 5 years of age, relief of symptoms of seasonal allergic rhinitis in patients 2 to 5 years of age.
• Manufacturer: Global Napi Pharmaceuticals

Key Benefits

• Effective Asthma Control: Helps prevent asthma attacks and reduce the frequency and severity of asthma symptoms, including wheezing and shortness of breath.
• Allergy Symptom Relief: Alleviates symptoms of seasonal allergies such as sneezing, runny nose, nasal congestion, and itchy, watery eyes.
• Convenient Chewable Form: Easy to administer for young children who may have difficulty swallowing pills.
• Once-Daily Dosing: Simple regimen that promotes compliance.
• Reduces Exercise-Induced Asthma: Can also be used to prevent bronchoconstriction caused by exercise.

How to Use

1. Always follow your doctor's instructions regarding dosage and duration of treatment.
2. For asthma and/or seasonal allergic rhinitis, the usual dose is one 4mg chewable tablet once daily in the evening.
3. For exercise-induced bronchoconstriction, take one 4mg chewable tablet at least 2 hours before exercise. Do not take a second dose within 24 hours.
4. The tablet should be chewed thoroughly before swallowing.
5. YOCAIR chewable tablets can be taken with or without food.
6. Continue taking YOCAIR as prescribed, even if you feel well, to maintain control of your asthma and allergies.

Ingredients

Each YOCAIR 4mg Chewable Tablet contains:

• Active: Montelukast (as Montelukast Sodium 4.16mg equivalent to Montelukast 4mg)
• Inactive Ingredients: Mannitol, Microcrystalline Cellulose, Hydroxypropyl Cellulose, Croscarmellose Sodium, Cherry Flavor, Red Iron Oxide, Magnesium Stearate, Aspartame.

Caution & Warnings

• Not for Acute Attacks: YOCAIR is not intended to treat acute asthma attacks. Always use a rapid-acting inhaled beta-agonist (rescue inhaler) for acute symptoms.
• Medical Consultation: Do not stop or reduce the dose of your other asthma medications unless directed by your doctor.
• Neuropsychiatric Events: Patients (especially children) should be monitored for neuropsychiatric events, including agitation, aggression, anxiety, depression, disorientation, disturbance in attention, dream abnormalities, hallucinations, insomnia, irritability, memory impairment, obsessive-compulsive symptoms, restlessness, somnambulism, suicidal ideation and behavior (including suicide), tic, and tremor. If such changes occur, consult your doctor immediately.
• Phenylketonuria Warning: Contains aspartame, a source of phenylalanine. Patients with phenylketonuria (PKU) should be informed.
• Hypersensitivity: Do not use if you are allergic to Montelukast or any other ingredients.
• Pregnancy and Breastfeeding: Consult your doctor before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.
• Storage: Keep out of reach and sight of children. Store in the original package below 30°C, protected from moisture and light.